CRIS Current Research Information System

BARBARA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.172
NA - Nord America 1.060
EU - Europa 692
SA - Sud America 160
AF - Africa 69
Totale 3.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.038
SG - Singapore 540
CN - Cina 270
HK - Hong Kong 161
SE - Svezia 139
BR - Brasile 127
VN - Vietnam 100
NL - Olanda 94
DE - Germania 93
IT - Italia 76
RU - Federazione Russa 63
IE - Irlanda 56
GB - Regno Unito 53
BG - Bulgaria 38
IN - India 29
KR - Corea 28
SC - Seychelles 23
CI - Costa d'Avorio 21
AR - Argentina 19
FI - Finlandia 15
FR - Francia 15
CH - Svizzera 14
CA - Canada 11
TG - Togo 11
UA - Ucraina 10
ID - Indonesia 9
JO - Giordania 9
MX - Messico 9
AT - Austria 8
JP - Giappone 8
ZA - Sudafrica 8
IR - Iran 7
PL - Polonia 7
EC - Ecuador 5
BD - Bangladesh 4
PY - Paraguay 4
ES - Italia 3
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
KE - Kenya 2
LT - Lituania 2
RO - Romania 2
TR - Turchia 2
AZ - Azerbaigian 1
BH - Bahrain 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
IQ - Iraq 1
IS - Islanda 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 3.153
Salva come PNG Salva come JPEG
Città #
Singapore 277
Santa Clara 215
Hong Kong 161
Chandler 114
Ashburn 105
Boardman 86
Beijing 78
Dublin 56
Princeton 48
Ho Chi Minh City 38
Southend 38
Sofia 34
Los Angeles 33
Hefei 28
Seoul 28
Berlin 22
Abidjan 21
Hanoi 18
New York 18
Buffalo 17
Redondo Beach 16
Bologna 15
Bern 14
Helsinki 14
Falkenstein 12
Guangzhou 12
Chicago 11
Dallas 11
Frankfurt am Main 11
Lomé 11
Milan 11
Houston 10
Amman 9
Amsterdam 8
Columbus 8
Nuremberg 8
Salt Lake City 8
Shanghai 8
Yubileyny 8
Boston 7
Mumbai 7
São Paulo 7
Bengaluru 6
Fairfield 6
Haiphong 6
Turin 6
Warsaw 6
Hangzhou 5
Kyiv 5
London 5
Manaus 5
Montreal 5
Phoenix 5
Washington 5
Belo Horizonte 4
Campinas 4
Fuzhou 4
Mexico City 4
Munich 4
Olalla 4
Rio de Janeiro 4
Tokyo 4
Wuhan 4
Biên Hòa 3
Brooklyn 3
Cambridge 3
Cape Town 3
Da Nang 3
Denver 3
Düsseldorf 3
Hải Dương 3
Kunming 3
La Plata 3
Ottawa 3
Perugia 3
Porto Alegre 3
Reggio Emilia 3
Salvador 3
Seattle 3
Shenzhen 3
The Dalles 3
Tianjin 3
Woodbridge 3
Andover 2
Ann Arbor 2
Asunción 2
Augusta 2
Azzano San Paolo 2
Bogor 2
Boydton 2
Brussels 2
Caruaru 2
Caxias do Sul 2
Cedar Knolls 2
Cesenatico 2
Chengdu 2
Chennai 2
Des Moines 2
Durban 2
Elk Grove Village 2
Totale 1.856
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 197
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 179
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 89
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 86
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 86
Cost-effectiveness analysis of the preparation of colonoscopy. Comparison between a PEG-electrolyte solution and a standard preparation 85
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 79
Interleukin 1 in ulcerative colitis 78
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 78
Role of rectal formulations: Enemas 76
Macrophage subpopulations in pouchitis 75
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 74
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 73
Bronchopulmonary involvement in ulcerative colitis 72
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 72
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 70
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 70
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 69
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 66
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 64
Pentasa in maintenance treatment of ulcerative colitis 63
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 61
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 61
Rifaximin suspension for the eradication of helicobacter pylori 53
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 50
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 44
Rifaximin suspension for the eradication of helicobacter pylori 43
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 43
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 39
Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist 37
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 37
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds 37
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 35
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 31
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 30
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 29
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 29
Serological response to Helicobacter pylori in gastric and non-gastric cancer 29
Serological response to Helicobacter pylori in gastric and non-gastric cancer 27
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 27
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 27
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 27
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 27
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 27
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 26
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 26
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 25
Lactose Malabsorption in Adult Patients with Crohn's Disease 25
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 24
Peptic ulcer disease and Helicobacter pylori infection 23
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 21
Optimal nutritional indexes in gastroenterology 20
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 19
Source of Helicobacter pylori Infection 19
Peptic ulcer disease and Helicobacter pylori infection 18
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 17
Biliary surgery without the surgeon! 17
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 17
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 17
Helicobacter pylori: its role in gastric disease 15
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 15
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 15
null 15
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 15
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 14
Prevalence of Helicobacter pylori in military barracks 14
Treatment of symptom-free Helicobacter pylori-positive subjects 14
Screening for Helicobacter pylori 13
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 13
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 13
Helicobacter pylori and other spiral organisms in gastroduodenal disease 13
Helicobacter pylori and other spiral organisms in gastroduodenal disease 13
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 12
Biliary surgery without the surgeon! 12
Helibacter pylori and gastroduodenal disease 12
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 12
Helicobacter pylori: its role in gastric disease 12
Helibacter pylori and gastroduodenal disease 12
Source of Helicobacter pylori Infection 11
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 9
Treatment of symptom-free Helicobacter pylori-positive subjects 8
Prevalence of Helicobacter pylori in military barracks 8
Totale 3.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 2 4 0 0 3
2021/2022258 0 1 1 4 2 1 1 2 81 33 100 32
2022/2023525 48 76 51 28 28 37 17 39 99 19 32 51
2023/2024270 73 33 23 24 21 49 6 22 3 13 3 0
2024/20251.109 41 81 65 60 325 50 89 38 10 110 23 217
2025/20261.084 137 182 251 170 251 93 0 0 0 0 0 0
Totale 3.255